- Q2 2024 Covalon Technologies Ltd Earnings Call TranscriptMay 29, 2024C$1.72 (+54.95%)Earnings
- Q3 2023 Covalon Technologies Ltd Earnings Call TranscriptAug 16, 2023C$1.74Earnings
- Q2 2023 Covalon Technologies Ltd Earnings Call TranscriptMay 25, 2023C$2.14 (+9.74%)Earnings
- Covalon Technologies Ltd at Precious Metals Summit Planet Microcap Showcase TranscriptApr 26, 2023
- Q1 2023 Covalon Technologies Ltd Earnings Call TranscriptFeb 23, 2023C$2.3 (+4.55%)Earnings
- Q4 2022 Covalon Technologies Ltd Earnings Call TranscriptJan 26, 2023C$2.18 (-3.11%)Earnings
- Covalon Technologies Ltd at Issuer Direct Planet MicroCap Showcase (Virtual) TranscriptDec 07, 2022
- Q3 2022 Covalon Technologies Ltd Earnings Call TranscriptAug 29, 2022C$2.51 (-7.72%)Earnings
- Q2 2022 Covalon Technologies Ltd Earnings Call TranscriptMay 30, 2022C$2.17 (+3.83%)Earnings
- Q1 2022 Covalon Technologies Ltd Earnings Call TranscriptMar 01, 2022C$2.35 (+6.33%)Earnings
- Q4 2021 Covalon Technologies Ltd Earnings Call TranscriptDec 13, 2021C$2.69Earnings
- Covalon Technologies Ltd at SNN Network Canada Virtual Event TranscriptDec 08, 2021
- Q3 2021 Covalon Technologies Ltd Earnings Call TranscriptAug 30, 2021C$2.05 (+9.63%)Earnings
- Q2 2021 Covalon Technologies Ltd Earnings Call TranscriptMay 31, 2021C$1.6 (+10.34%)Earnings
- Q1 2021 Covalon Technologies Ltd Earnings Call TranscriptMar 01, 2021C$1.7 (-3.41%)Earnings
- Q4 2020 Covalon Technologies Ltd Earnings Call TranscriptJan 28, 2021C$1.49 (+8.76%)Earnings
- Q3 2020 Covalon Technologies Ltd Earnings Call TranscriptAug 24, 2020C$1.14 (+21.28%)Earnings
- Q2 2020 Covalon Technologies Ltd Earnings Call TranscriptJul 15, 2020C$1.16 (-15.33%)Earnings
- Covalon Technologies Ltd Corporate Call to Discuss CovaGuard Antimicrobial Technology TranscriptApr 06, 2020
- Q1 2020 Covalon Technologies Ltd Earnings Call TranscriptMar 03, 2020C$1.84 (+11.52%)Earnings
- Q4 2019 Covalon Technologies Ltd Earnings Call TranscriptJan 29, 2020C$1.88 (-4.08%)Earnings
Q2 2021 Covalon Technologies Ltd Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to Covalon's fiscal 2021 second-quarter financial results conference call. My name is Harris, and I will be your conference operator today. As a reminder, today's conference is being recorded. All lines have been placed on mute to prevent any background noise.
At this time, I would like to turn the conference over to Mr. Brian Pedlar, Chief Executive Officer; and Mr. Danny Brannagan, Chief Financial Officer. Please go ahead, Mr. Pedlar and Mr. Brannagan.
Thank you. My name is Danny Brannagan. And as Covalon's Chief Financial Officer, I'd like to thank everyone for taking the time this morning to attend our conference call. We will be discussing the financial statements, MD&A, and press release related to Covalon's second quarter and six months ended March 31, 2021. There will be an opportunity for you to ask questions at the end of our call.
Before we begin the discussion, I would like to remind participants that this call is covered by
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)